Altogether, these results indicated that Sox9+ luminal cells can serve as cells of origin for basal-like carcinomas driven by LATS1/2 deletion, reinforcing the implication of this lineage as an origin for basal-like breast cancers. The gene discussed is SOX9; the disease is carcinoma.